Assess the Effects of Medications and Other Treatments

Skip to main content
NeuroPace, Inc.
  • Patients
  • Providers
  • Corporate
  • PDMS
  • nSight
  • Take the Quiz
  • Product
    • The RNS System
    • nSight Platform
    • MRI Safety
    • DIXI US Products
  • Clinical Benefits
    • Seizure Reduction
    • Quality of Life
    • Proven Safety
  • Actionable Insights
    • Real World EEG Data
    • Monitor Patients Remotely
    • Assess Treatment Effects
    • Counsel Patients
  • Patient Selection
    • Neocortical
    • Mesial Temporal
  • Education
    • Webinars
    • RNS System Education
    • Fellows Education
    • Programming Resources
  • Clinical Trials
  • Resources
    • Publications
    • Physician Product Manuals
    • Reimbursement References
    • MRI Guidelines
  • Product
    • The RNS System
    • nSight Platform
    • MRI Safety
    • DIXI US Products
  • Clinical Benefits
    • Seizure Reduction
    • Quality of Life
    • Proven Safety
  • Actionable Insights
    • Real World EEG Data
    • Monitor Patients Remotely
    • Assess Treatment Effects
    • Counsel Patients
  • Patient Selection
    • Neocortical
    • Mesial Temporal
  • Education
    • Webinars
    • RNS System Education
    • Fellows Education
    • Programming Resources
  • Clinical Trials
  • Resources
    • Publications
    • Physician Product Manuals
    • Reimbursement References
    • MRI Guidelines
Press enter to begin your search

Assess the Effects of Medications and Other Treatments

“Inaccurate seizure counts can make it difficult for clinicians to understand how to assess the efficacy of current treatments or move forward with changes in AEDs or other treatment strategies.” 1

Objective Data to Help You Optimize Treatment Plans

The RNS® System is the only epilepsy therapy that empowers you with real-world intracranial EEG (iEEG) data that can help you gain insight into the effects of other therapies.

icon with different medications
Early Assessment of Anti-Epileptic Drugs

Early Assessment of Anti-Epileptic Drugs (AEDs)

iEEG data recorded by the RNS System may provide an early assessment of whether an adjunctive AED is likely to improve seizure frequency.2
Read About AED Assessment

Gain Insight into the Effects of Other Treatments

In two case studies, electrographic changes observed with RNS System data corresponded with improved clinical outcomes when assessing both the ketogenic diet and cannabidiol.3,4,†

Assessing the Ketogenic Diet

In this case study, a reduction in event detections by the RNS System was coincident with initiation of the ketogenic diet.3,†

Assessing the Ketogenic Diet

Assessing Epidiolex

Red arrow indicates initiation of Cannabidiol. Patient reported seizure freedom after initiation, which correlates with a decrease in number of event detections by the RNS System.4,†

Assessing epidiolex

1. Halpern, CH, and Mirro, EA, Neurosurgery, 2020., 2. Quraishi, et al, Epilepsia, 2020, 3. Greenwood, et al., AAN 2019., 4. Greenwood et al., AAN 2019.
†This is a single patient case study and caution must be taken while interpreting results.

More questions? Contact an RNS System Professional.

Send a message

  • Safety Information
  • Legal
  • Privacy Policy
1-866-726-387624-hr Support Line

PATIENTS

  • Drug-Resistant Epilepsy
  • The RNS System
  • Hear from Patients
  • Is It Right for You?
  • Current Patients
  • Resources

PROVIDERS

  • Product
  • Clinical Benefits
  • Actionable Insights
  • Patient Selection
  • Education & Training
  • Resources

ABOUT US

  • In The News
  • Press Releases
  • Leadership
  • Careers
  • Contact Us
  • FCOI Procedure
  • PATIENTS

    Safety
  • PROVIDERS

    Legal
  • INVESTORS

    Privacy Policy
  • ABOUT US

1-866-726-3876 24-hr Support Line

© 2026 NeuroPace, Inc..

Step 1 of 7

14%
    The RNS System is for individuals 18 and older who have focal epilepsy and have tried two or more medications without finding seizure control.
  • Based on your answers, your patient might benefit from the RNS System.

    Get your profile and a list of questions to ask your doctor.

  • Unfortunately it appears your patient is not an appropriate candidate for the RNS® System at this time.

  • The RNS® System is intended for patients who have undergone diagnostic testing that localized no more than 2 epileptogenic foci.

    If your patient has not undergone diagnostic testing, search here to find a comprehensive epilepsy center that can evaluate your patient, including determining if the RNS System is right for them.

  • If you are interested in learning more about the RNS® System, you can have an RNS® System professional contact you by filling out the form below:

  • By filling out this form, you are agreeing to the terms of our privacy policy. This form is intended for US residents only.

    By clicking submit, you are agreeing to receive communications from NeuroPace. You can unsubscribe at any time.

    * Required fileds

Share your Story: Terms and conditions

By filling out the form and submitting your story (and/or photograph), you are agreeing to the following:

  1. NeuroPace may review the information and any photographs you provide for potential publication on our website.
  2. If NeuroPace decides to use your story, we will contact you and ask you to sign a release for a version of your story to be used on the NeuroPace website, Facebook, Instagram, Twitter and/or LinkedIn. Unless you sign the release, we will not publish the story, your name, or the photographs you provided.
  3. Regardless of whether we publish your story, we will add your name and e-mail address to the NeuroPace email list to hear from us about product updates, upcoming events and other relevant information. We will not sell your information to third parties. 
  4. Our use of your information is subject to our Privacy Policy, which you can access here.
neuropace logoLogo Header Menu
  • Patients
  • Providers
  • Corporate
  • PDMS
  • nSight
  • Take the Quiz